媒體:
561
建立:
2025/10/02
管理者:
TUA線上教育_家琳
  1. 知識庫
  2. ...
  3. 年會
  4. 2025年會 (UAA)
  5. 摘要
管理者：TUA線上教育_家琳
  1. 1.
    Free Paper <Podium> (1) Oncology Prostate (A)
    1. 1.1
      #0041 Big Database: Multicenter prospective study of histoscan-guided prostate biopsy in the early detection of prostate cancer
    2. 1.2
      #0042 Clinical Decision Support Systems (CDSS) for detecting the presence of an oncological process in the prostate in patients with suspected prostate cancer
    3. 1.3
      #0083 A Precision Diagnostic and Therapeutic Platform for Prostate Cancer Based on Intelligent Nucleic Acid Nanomachines
    4. 1.4
      #0088 Oncological and Functional outcomes of Hemi Ablation versus Focal Ablation for Localized Prostate Cancer using Irreversible Electroporation
    5. 1.5
      #0089 The Diagnostic value of MRI for Persistent Prostate Cancer following Irreversible Electroporation Focal Therapy: Results from a Randomized Controlled Trial
    6. 1.6
      #0090 Focal Cryotherapy for clinically significant prostate cancer: Oncological and functional outcomes of a prospective observational extension of a Phase II clinical trial
    7. 1.7
      #0093 Comparison of survival in patients with low vs intermediate prostate-specific antigen concentrations and development of a predictive nomogram: A SEER database study with external validation on a Chinese cohort
    8. 1.8
      #0103 Intraoperative anastomotic urinary leakage following Retzius-sparing robot-assisted radical prostatectomy
    9. 1.9
      #0729 A Head-to-head Comparison of Micro-Ultrasound Guided Cognitive Prostate Biopsy and Conventional Robotic assisted MRI-fusion Prostate Biopsy In An Asian Setting
    10. 1.10
      #0779 Feasibility of Da Vinci SP system on extraperitoneal-approach radical prostatectomy in Taiwan: the initial results of SPEAR-P trial
    11. 1.11
      #1047 Pattern of care and survival outcomes in older men with localised prostate cancer in an Australian population-based cohort
    12. 1.12
      #1059 Clinical Registry Protocol for FIREFLY: A Clinical Registry of Focal Irreversible Electroporation in Men with Biopsy Confirmed Low-Intermediate Risk Prostate Cancer
    13. 1.13
      #1060 The effect of diabetes mellitus on serum PSA levels, a systematic literature review
    14. 1.14
      #1121 Single Centre Experience of Robot Assisted Radical Prostatectomy with CMR Versius® Robotic Surgical System
    15. 1.15
      #1187 Impact of AirSeal® on peri-operative outcomes in robotic-assisted partial nephrectomy: a retrospective comparative study
  2. 2.
    Free Paper <Podium> (2) Endourology (A)
    1. 2.1
      #0149 ANALYSIS OF KIDNEY STONE COMPOSITION BY AGE AND GENDER
    2. 2.2
      #0164 Could a flexible and navigable suction ureteral access sheath be a potential game-changer to decrease the need for high-power lasers in retrograde intrarenal surgery?
    3. 2.3
      #0193 Innovations in Urological Surgery: Evaluating the Effects of Dexamethasone on Pain Management in Ureteral Stone Procedures
    4. 2.4
      #0429 Comparison of postoperative quality of life between patients with symptomatic and asymptomatic non-obstructing kidney stones
    5. 2.5
      #0540 Validation of the BURST collaborative score for likelihood of spontaneous ureteral calculus passage in an Australian cohort
    6. 2.6
      #0547 Novel Pulsed Thulium:YAG laser & retrograde intrarenal surgery for urolithiasis: A retrospective single centre experience in the United Kingdom
    7. 2.7
      #0555 Urinary Glyphosate Levels and Kidney Stone Incidence: A Combined Clinical and Network Toxicology Approach
    8. 2.8
      #0635 Intraoperative Bilateral Intrarenal Pressure Measurement during Retrograde Intrarenal Surgery: Real-Time Comparison with Normal Contralateral Pressure
    9. 2.9
      #0720 Learning Curve Analysis of Modified Lateral Position PCNL with Extended Legs: A Single Urologist’s Experience Over 70 Cases
    10. 2.10
      #0731 Holmium MOSESTM Laser versus Thulium Fiber Laser for Ureteroscopic Management of 1-2cm Kidney Stones: A Prospective Randomized Controlled Trial
    11. 2.11
      #0735 EVALUATE THE RESULTS OF SINGLE-ACCESS PERCUTANEOUS NEPHROLITHOTOMY FOR STAGHORN STONES
    12. 2.12
      #0835 The Incidence of Re-Look Pyeloscopy within an Australian Tertiary Stone Hospital.
    13. 2.13
      #0885 A Simplified Risk Score for Predicting Prolonged RIRS Operative Time: Practicality Over Complexity
    14. 2.14
      #1019 Development of a Novel Clinical Prediction Model for the Number of ESWL (Extracorporeal Shock Wave Lithotripsy) Sessions Needed for Stone Clearance
    15. 2.15
      #1197 Evidence-Based Opioid Prescribing and Patient-Reported Pain Outcomes after Percutaneous Nephrolithotomy
  3. 3.
    Free Paper <Podium> (3) Oncology Bladder UTUC (A)
    1. 3.1
      #0065 BCG response and oncological outcomes in high risk non-muscle invasive bladder cancer following previously treated upper tract urothelial carcinoma: A propensity-matched analysis
    2. 3.2
      #0094 Prediction Nomograms of Prognosis in Bladder Urothelial Carcinoma Patients Receiving Radical Cystectomy-A Two-center Retrospective Research
    3. 3.3
      #0131 Preclinical assessment of anti-PVR antibody-drug conjugate in bladder urothelial carcinoma
    4. 3.4
      #0215 META-ANALYTICAL ASSESSMENT ABOUT STANDARD AND EXTENDED PELVIC LYMPH NODE DISSECTION IN TERMS OF POST-OPERATIVE COMPLICATIONS IN PATIENTS UNDER RADICAL CYSTECTOMY
    5. 3.5
      #0216 Anemia is associated with inferior outcomes in non-muscle invasive bladder cancer patients receiving Bacillus Calmette-Guérin immunotherapy
    6. 3.6
      #0221 Treatment of Muscle Invasive Bladder Cancer in the Elderly: A systematic review and meta-analysis
    7. 3.7
      #0295 Enhancing Individual Survival Prediction in Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy Using Machine and Deep Learning AI models
    8. 3.8
      #0298 CD163+ Tumor-Associated Macrophages and GATA3 Expression: Promising Markers for Predicting Post-Surgery Progression in Locally Advanced Upper Tract Urothelial Carcinoma
    9. 3.9
      #0362 Comprehensive Bioinformatics Approach for Identifying Lipid-Related Markers in Bladder Cancer Prognosis
    10. 3.10
      #0371 The use patient-derived prostate cancer organoids as a tool to predict response to therapy
    11. 3.11
      #0406 The comparison of robotic-assisted and laparoscopic radical nephroureterectomy in non-metastatic upper tract urothelial carcinoma
    12. 3.12
      #0411 Effect of statin use on outcomes of non-muscle-invasive bladder cancer: a systematic review and meta-analysis
    13. 3.13
      #0812 Infrapubic Foley catheter balloon tamponade for retropubic venous haemorrhage during radical cystoprostatectomy and urethrectomy
    14. 3.14
      #1273 Hyperthermia Intravesical Chemotherapy vs. Bacillus Calmette-Guérin instillation and Mitomycin C Perfusion for Non-muscle-invasive Bladder Cancer: A Network Meta-analysis
    15. 3.15
      #1311 Nano-Ni0 nanocatalysts disrupt redox homeostasis via hydrogen-induced reductive stress and nickel-driven chemodynamic therapy for bladder cancer treatment and immune modulation
  4. 4.
    Free Paper <Podium> (4) Infectious Disease & Urologic Trauma
    1. 4.1
      #0096 Predictors of Hemorrhage after Partial Nephrectomy for Stage T1 Renal Cell Carcinoma: 10-year Experience from a Regional Medical Center in Eastern China
    2. 4.2
      #0098 Construction of a predictive model for pT3a risk in cT1 renal cell carcinoma using perioperative characteristics: a comparison of various machine learning techniques with adaptive synthetic sampling
    3. 4.3
      #0114 National Early Warning Score 2 (NEWS2) and Quick Sequential Organ Failure Assessment (qSOFA) Score in Acute Pyelonephritis: Tools for Expedited Care and Improved Outcomes
    4. 4.4
      #0115 Role of Relook Flexible Ureteroscopy in Post-Stenting Management of Acute Pyelonephritis: Where We Miss the Boat
    5. 4.5
      #0144 Salinomycin inhibits SREBP1 to sensitizes ferroptosis and ameliorate sorafenib resistance in clear cell renal cell carcinoma
    6. 4.6
      #0155 Histological features suggestive of survival in patients with renal cell carcinoma and tumor thrombus: A singlecenter experience
    7. 4.7
      #0219 Insufficient S-sulfhydration of cAMP-response element binding protein participates in kidney fibrosis via promoting epithelial-mesenchymal transition
    8. 4.8
      #0430 Risk of cystoscopy-related urinary tract infections with Pseudomonas aeruginosa
    9. 4.9
      #0439 Management of Self-Inserted Foreign Bodies in the Lower Urinary Tract: A Case Series and Literature Review
    10. 4.10
      #0460 Bacterial Vaccines for Preventing Recurrent Urinary Tract Infections: A Systematic Review and Meta-Analysis
    11. 4.11
      #0600 To Drain or not to Drain? Surgical Decision Making in Prostate Abscess
    12. 4.12
      #0657 Comparative Analysis of Graft Options for Urethral Stricture: Implications for Qmax, Erectile Dysfunction, and Quality of Life: A Systematic Review and Meta Analysis
    13. 4.13
      #0819 Burkholderia pseudomallei prostate abscess drainage: a single-center case series
    14. 4.14
      #1219 Clinical spectrum, surgical management and outcomes of Genitourinary Tuberculosis: A tertiary care center experience.
    15. 4.15
      #1294 APPLICATION OF THE SOFA AND QSOFA SCORES IN DIAGNOSIS AND MANAGEMENT OF SEPSIS AND SEPTIC SHOCK FROM URINARY TRACT INFECTIONS AT HO CHI MINH CITY UNIVERSITY MEDICAL CENTER
  5. 5.
    Free Paper <Podium> (5) Transplantation
    1. 5.1
      #0130 Comprehensive Genomic and Proteomic Profiling of Adrenocortical Carcinoma in Chinese Patients Identifies an IDH1-Mutant Subtype with Therapeutic Implications
    2. 5.2
      #0178 Comparative analysis of CT Volumetry vs. Nuclear Imaging (Dimercaptosuccinic acid) scan in predicting early post-donation renal function using split renal function.
    3. 5.3
      #0182 Supramolecular Assembly-Enabled Cancer Theranostics through Concurrent Ferroptosis-Apoptosis
    4. 5.4
      #0185 DMSA-based pre-donation differential renal function does not significantly impact the new baseline glomerular filtration rate: A retrospective five-year cohort study of 124 kidney donors.
    5. 5.5
      #0192 Finding Peace: The Role of Religiosity in Alleviating Preoperative Anxiety in Renal Transplant Patients
    6. 5.6
      #0217 Febuxostat facilitates neovasculogenesis in chronic kidney disease through xanthine oxidase signaling pathways
    7. 5.7
      #0315 Stem cell-based synthetic kidney organoid model for renal replacement therapy
    8. 5.8
      #0356 Artificial intelligence to identify surgical anatomy for intraoperative guidance during laparoscopic donor nephrectomy
    9. 5.9
      #0415 Long-term kidney function and survival after living donor nephrectomy in individuals with hepatitis B virus infection: a controlled cohort study
    10. 5.10
      #0572 Effects of second warm ischemic time on delayed graft function in kidney transplant: retrospective review from a local transplant centre
    11. 5.11
      #0871 Correlation of Sexual Hormones in Chronic Kidney Disease Stages
    12. 5.12
      #0931 LEARNING CURVE OF ROBOTIC LIVING DONOR NEPHRECTOMY: RESULTS FROM A HIGH VOLUME TRANSPLANTATION CENTER
    13. 5.13
      #1181 Impact of the COVID-19 Pandemic on Kidney Transplantation in Australia: A 20-Year National Retrospective Study
    14. 5.14
      #1297 Endometrial Regeneration Cell-derived Exosomes Carrying siCD3 Inhibit Kidney Allograft Rejection through Suppression of α-2,6 Sialylation
    15. 5.15
      #1336 Carbon dots mitigate renal ischemia-reperfusion injury by inhibiting ferroptosis: a targeted and biocompatible strategy for acute kidney injury in transplantation
  6. 6.
    Free Paper <Podium> (6) Training and Education & AI in Urology
    1. 6.1
      #0045 The learning curve for retrograde intrarenal surgery (RIRS) in group of residents: experience of the Moscow urological center
    2. 6.2
      #0080 Navigating the Skies: My Journey to Earning a Private Pilot License (PPL) and Become a Licensed Urologist and a Licensed Pilot
    3. 6.3
      #0197 Deep Neural Network and Machine Learning Radiomic Model for Renal Tumors as Accuracy in Diagnosis and Operative Planning
    4. 6.4
      #0307 Do AI Language Models Outperform Human Experts? Benchmarking Nine Models in Stage IV Prostate Cancer Risk Assessment and Feature Stratification
    5. 6.5
      #0463 Improving Knowledge and Confidence in Continuous Bladder Irrigation: A Nursing Education Program in the Emergency Department
    6. 6.6
      #0493 AI-Based Automatic Estimation of Single-Kidney Glomerular Filtration Rate and Split Renal Function Using Non-Contrast CT
    7. 6.7
      #0569 Evaluation of AI and Radiologist contouring on prostate MRI for targeted MRI/US fusion biopsy
    8. 6.8
      #0638 An artificial intelligence system for renal stone imaging diagnosis and prediction of postoperative stone free status
    9. 6.9
      #0678 Enhancing Surgical Capacity in Low to Middle-Income Countries: An Initiative Study of Global Surgery Experience in Pediatric and Reconstructive Urology
    10. 6.10
      #1033 What can we learn from non significant primary endpoints? A reanalysis of non-significant primary endpoints in Urological RCT's
    11. 6.11
      #1051 Misleading reporting of Urological RCT's with non-significant primary endpoints
    12. 6.12
      #1071 Psychological Impact of Urological Disorders on Men’s Mental Health: A Call for Integrated Support
    13. 6.13
      #1078 Assessing First-Year Junior Doctors' Competence and Confidence in Urethral Catheterisation: An Australian Multicentre Cross-Sectional Study
    14. 6.14
      #1265 Deep learning-based multi-model prediction for disease-free survival status of patients with clear cell renal cell carcinoma after surgery: a multicenter cohort study
  7. 7.
    Free Paper <Podium> (7) Oncology Prostate (B)
    1. 7.1
      #0168 Prognostic Comparison of Surgical Modalities in Early-Stage Prostate Cancer: Development and Validation of a Survival Prediction Nomogram
    2. 7.2
      #0187 Association of Hyaluronic Acid Rectal Spacer Quality Metrics with Rectal Dosimetry and Acute and Late Gastrointestinal (GI) Toxicity Outcomes
    3. 7.3
      #0196 Combined Prostate-specific Membrane Antigen Positron Emission Tomography (PSMA-PET) and multiparametric Magnetic Resonance Imaging (mpMRI) for the diagnosis of clinically significant prostate cancer (csPCa)
    4. 7.4
      #0201 Suprapubic vs urethral catheters post robotic-assisted radical prostatectomy
    5. 7.5
      #0205 Reducing Unnecessary Biopsies in PI-RADS 3-4 Lesions Through PSA-Derived Biomarker Integration: A Decision Curve Analysis
    6. 7.6
      #0213 Prostate Cancer Detection using Artemis Prostate Fusion biopsy in a Single Institution : A Retrospective Study
    7. 7.7
      #0230 Role of systematic biopsies in suspected carcinoma prostate patients and analysis of Gleason grade group concordance between the biopsy and histopathology report following radical prostatectomy.
    8. 7.8
      #0246 Focal Laser Ablation in Prostate Cancer: A systematic review and meta-analysis
    9. 7.9
      #0283 Integrating Multi-Cohort Machine Learning and Clinical Validation to Explore Peripheral Blood mRNA Diagnostic Biomarkers for Prostate Cancer
    10. 7.10
      #0330 Development and Validation of a Novel Technique for Precise Diagnosis of DNA Mutations in Prostate Cancer
    11. 7.11
      #0331 Development and Application of a ctDNA Methylation Detection Platform for Prostate Cancer
    12. 7.12
      #0370 Chimeric Antigen Receptor T-Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer: A review of all clinical and preclinical trials.
    13. 7.13
      #0422 Extremity cooling for the prevention of Taxane-Induced nail changes and neuropathy in castration-resistant prostate cancer: Prospective intrapatient comparison study
    14. 7.14
      #0425 Optimizing Biopsy Core Number in MRI-Fusion Prostate Biopsy: A Single-Center Experience
  8. 8.
    Free Paper <Podium> (8) Oncology Bladder UTUC (B)
    1. 8.1
      #0154 Survival of Patients With UrAC and Primary BAC and Urothelial Carcinoma With Glandular Differentiation
    2. 8.2
      #0417 Modulating Immune Response in Radical Cystectomy: The Role of Pre-Operative Immunomodulatory Nutrition on IL-10, CD4+, CD8+, and Albumin Levels
    3. 8.3
      #0420 Evaluating the Performance of Cxbladder Triage and Detect and Imaging for the Detection of Urothelial Cancer in Patients with Gross Hematuria: A Canterbury, New Zealand Audit
    4. 8.4
      #0449 Physician and patient preferences for early-stage and adjuvant treatment of genitourinary cancer in Asia-Pacific
    5. 8.5
      #0451 THE DIAGNOSTIC PERFORMANCE OF CXBLADDER TRIAGE PLUS FOR THE IDENTIFICATION AND PRIORITY EVALUATION OF VETERANS AT RISK FOR UROTHELIAL CARCINOMA: THE DRIVE STUDY
    6. 8.6
      #0464 The LOngitudinal Bladder cancer Study for Tumour rEcurRence (LOBSTER) Study of Cxbladder Monitor and Monitor Plus for Recurrence of Urothelial Carcinoma in Low, Intermediate, and High-Risk Patients: Trial in Progress
    7. 8.7
      #0515 The Australian Urologic risk Stratification of patientS wIth hEmaturia (AUSSIE) Study of Cxbladder Performance for the Detection of Urothelial Carcinoma in Patients with Hematuria: Trial in Progress
    8. 8.8
      #0585 Enfortumab Vedotin Plus Pembrolizumab Versus Chemotherapy in Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma: Updated Analysis of the Pan-Asian Subgroup from EV-302/KEYNOTE-A39
    9. 8.9
      #0596 Impact of Immune Checkpoint Inhibitors as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis
    10. 8.10
      #0677 Development of Nomogram predicting outcome following radical cystectomy for bladder cancer :Data of Siriraj hospital , Thailand
    11. 8.11
      #0705 Long-term oncologic outcomes following laparoscopic radical nephroureterectomy: Contemporary analysis from a Japanese multicenter study
    12. 8.12
      #0761 Disitamab Vedotin in Combination with Immune Checkpoint Inhibitors as Neoadjuvant Therapy for Cisplatin-Intolerant Patients with Muscle-Invasive Bladder Cancer: A Real-World Retrospective Analysis
    13. 8.13
      #0792 Biomarker Detection for Predicting the Efficacy of Neoadjuvant RC48-ADC Combined with Immunotherapy in MIBC Patients Using Single-Cell Sequencing
    14. 8.14
      #0802 Epidemiology and Management Challenges of Bladder Cancer in Southeast Asia: Trends, Opportunities, and Future Directions
  9. 9.
    Free Paper <Podium> (9) Endourology (B)
    1. 9.1
      #0470 Outcome of Intralesional Mitomycin C with Optical Internal Urethrotomy and Optical Internal Urethrotomy with Clean Intermittent Self Catheterization in the Treatment of Bulbar Urethral Stricture
    2. 9.2
      #0715 Tandem ureteric stenting for malignant ureteral obstruction: A systematic review and meta-analysis
    3. 9.3
      #0894 Revitalizing Standard Percutaneous Nephrolithotomy: Impact of Technological and Radiological Advancements on Outcomes for Large Renal Stones - A large scale retrospective study
    4. 9.4
      #0947 Clinical Outcomes of Mini-Percutaneous Nephrolithotomy (mini-PCNL) and Retrograde Intrarenal Surgery (RIRS) for the Management of Large Renal Stones: A Meta-Analysis
    5. 9.5
      #0966 Efficacy of different surgical treatment modalities for radiation cystitis- lessons from 7 years of a specialist radiation cystitis service.
    6. 9.6
      #0968 Renal tubular epithelial cells-derived exosomal CD147 enhances matrix metalloproteinases expression and promotes kidney crystal depositions
    7. 9.7
      #1008 Luteolin Attenuates Hyperoxaluria-Driven Renal Inflammatory Pathology and Suppresses Calcium Oxalate Crystallization via Dual Mechanistic Pathways
    8. 9.8
      #1013 Unraveling the Protective Mechanism of Epicatechin Against Nephrolithiasis Through Network Pharmacology and Experimental Validation
    9. 9.9
      #1250 Synchronous Calculus and Malignant Lesions of The Kidneys Sequential PCNL Followed by Laparoscopic Partial Nephrectomy for Optimal Kidney Function Preservation
    10. 9.10
      #1281 Prone Endoscopic Combined Intrarenal Surgery: A Case Series on the Experience and Outcomes in Jose R. Reyes Memorial Medical Center, Manila, Philippines
    11. 9.11
      #1380 Comparing Irrigation Techniques During Flexible Cystoscopy: A Prospective Randomised Controlled Trial on Pain Reduction Using Pressure Bag Irrigation
    12. 9.12
      #1410 MANAGEMENT OF COMPLEX LEFT STAGHORN CALCULUS IN A POST OPEN RENAL STONE SURGERY VIA ENDOSCOPIC COMBINED INTRARENAL SURGERY: A CASE REPORT
    13. 9.13
      #1428 A Prospective, Comparative Study on a Renal Collecting System Sterilization with Antibiotic Irrigation During Retrograde Intrarenal Surgery
    14. 9.14
      #1431 Prospective Single-Center Study of SuperPulsed Thulium Fiber Laser in Retrograde Intrarenal Surgery: Our experience of 200 cases
  10. 10.
    Free Paper <Podium> (10) Oncology RCC (A)
    1. 10.1
      #0157 Papillary renal neoplasm with reverse polarity—comparative study with CCPRCC, OPRCC, and PRCC1
    2. 10.2
      #0162 Renal angiomyolipoma with tumor thrombi: Clinical analysis of 18 cases in a single-center experience
    3. 10.3
      #0163 Concurrent Germline and Somatic Mutations in FLCN and Preliminary Exploration of Its Function
    4. 10.4
      #0453 Metastatic RCC presenting as a pyogenic granuloma - A very rare presentation
    5. 10.5
      #0467 RhoJ Regulates Epithelial-Mesenchymal Transition in Renal Cell Carcinoma via TNF-α/NF-κB
    6. 10.6
      #0512 Performance of 68Ga-PSMA-11 PET/CT for diagnosing tumor thrombus and predicting response to pembrolizumab and axitinib in patients with renal cell carcinoma: a pilot, retrospective study
    7. 10.7
      #0545 Heterogeneity of [68Ga] Ga‑PSMA‑11 PET/CT in the assessment of therapy response in metastatic renal cell carcinoma treated with immune checkpoint inhibitors plus tyrosine kinase inhibitors
    8. 10.8
      #0550 PRKAB2 as a Tumor Suppressor in Renal Cell Carcinoma: Inhibiting Mitophagy via LRPPRC-Parkin Interaction and Cardiolipin Biosynthesis
    9. 10.9
      #0597 Evaluation of Angiogenic Potential in PSMA-Positive Tumor Vessels Surrounding Renal Cell Carcinoma Using High-Resolution Spatial Gene Expression Analysis
    10. 10.10
      #0756 Robot-assisted Surgical Strategies for Inferior Vena Cava Thrombus with Special Morphology: How to Balance Tumor Control and Functional Preservation?
    11. 10.11
      #0758 Prediction model for postoperative acute kidney injury and chronic kidney disease in patients with renal cell carcinoma and venous tumor thrombus
    12. 10.12
      #0760 Risk Factors of Preoperative Renal Dysfunction and its Impact on Survival in Patients with Renal Tumor and Inferior Vena Cava Tumor Thrombus
    13. 10.13
      #0765 Genotypic characterization and diagnostic efficacy of aldo-keto reductase family 1 member B10 (AKR1B10) immunohistochemistry in fumarate hydratase-deficient renal cell carcinoma among Taiwanese patients
    14. 10.14
      #0771 Unexpected presentation: metastatic adenoid cystic carcinoma (AdCC) of the breast masquerading as a large cystic-solid renal mass
  11. 11.
    Free Paper <Podium> (11) Pediatric Urology
    1. 11.1
      #0139 GRANULAR CELL TUMOR OF THE CLITORIS IN AN ADOLESCENT FEMALE: A CASE REPORT
    2. 11.2
      #0150 Hui-Jing Technique for One-stage Severe Primary Hypospadias Repair: Long-term Analysis Compared to the Bracka Technique
    3. 11.3
      #0151 A Case Description and Literature Analysis: Robotic-assisted Laparoscopic Transposition of the Left Renal Vein with Three-dimensional Image Reconstruction for treatment of the Pediatric Nutcracker Syndrome
    4. 11.4
      #0189 Comparative Analysis of Treatment Effectiveness for Giggle Incontinence in Boys and Girls
    5. 11.5
      #0299 Gender Assignment of the Virilized Female in Congenital Adrenal Hyperplasia
    6. 11.6
      #0401 Where Do We Stand with Hyperbaric Oxygen Therapy in Hypospadias, A Review of the Literature
    7. 11.7
      #0416 Predictors of Germ Cell Remnants in Unilateral Nodular Testis: Implications for Laparoscopic Decision-Making
    8. 11.8
      #0561 Usefulness of virtual reality application in pediatric urology
    9. 11.9
      #0780 Evaluation of Risk Factors for Urinary Tract Dilatation in Preterm Infants
    10. 11.10
      #0785 Robot-Assisted Laparoscopic Pyeloplasty for Ureteropelvic Junction Obstruction in Infants Under Three Months of Age
    11. 11.11
      #1125 GLANS-MEATUS-SHAFT SCORING AS A PARAMETER IN PREDICTING THE LEVEL OF ACCEPTANCE AND QUALITY OF LIFE OF POST HYPOSPADIAS REPAIR PATIENTS: A SINGLE INSTITUTION REVIEW
    12. 11.12
      #1202 Paratesticular Rhabdomyosarcoma in a 12-Year-Old Boy: A Case Report
    13. 11.13
      #1427 Robotic Left Transmesocolic Pyeloplasty in Pediatric PUJO: Comparing Efficacy and Outcomes to Traditional Pyeloplasty
    14. 11.14
      #1434 Robotic-Assisted Laparoscopic Pyeloplasty (RALP) in Children with Complex Pelvi Ureteric Junction Obstructions (PUJO) - A Retrospective Study
  12. 12.
    Free Paper <Podium> (12) Oncology Prostate (C)
    1. 12.1
      #0231 Radical prostatectomy without prostate biopsy based on a noninvasive diagnostic strategy: a prospective single center study
    2. 12.2
      #0374 Investigating Combination Therapy of Prostate-Specific Membrane Antigen Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer: A System Review and Meta-Analysis
    3. 12.3
      #0398 The Prognosis Prediction Value And Therapeutic Potential Of Anoikis-related Gene BUB1 In Prostate Cancer
    4. 12.4
      #0497 Impact of positive surgical margin location after radical prostatectomy: a network meta-analysis
    5. 12.5
      #0500 The Effect of Prostate MRI on NCCN prostate cancer risk stratification
    6. 12.6
      #0517 Disease Characteristics, Treatment Patterns and Oncological Outcomes of de-novo Metastatic Hormone-Sensitive Prostate Cancer: Real-world Experience from a multi-centre Asian cohort
    7. 12.7
      #0563 Irreversible Electroporation (IRE) for localised prostate cancer: initial experiences at an academic centre
    8. 12.8
      #0593 MRI-Targeted vs. Systematic TRUS Biopsy: Diagnostic Accuracy across PSA Levels
    9. 12.9
      #0599 Predictive Value of PSA Density for Biochemical Recurrence and Persistent PSA after Radical Prostatectomy in Localized Prostate Cancer
    10. 12.10
      #0620 Association between androgen receptor pathway inhibitors and adverse cardiovascular events: a retrospective cohort study in a large tertiary centre
    11. 12.11
      #0639 EXTERNAL VALIDATION OF THE PROSTATE BIOPSY COLLABORATIVE GROUP AND EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER RISK CALCULATORS IN MULTI-ETHNIC MALAYSIA
    12. 12.12
      #0645 PSMA PET as a tool for Active Surveillance- Where are we at? Current Evidence and future directions
  13. 13.
    Free Paper <Podium> (13) Oncology Bladder UTUC (C)
    1. 13.1
      #0859 SIX1 Promotes Bladder Cancer Stemness by Repressing DHRS2-Mediated lysosomal degradation of CD44
    2. 13.2
      #0878 Elevating Surgical Standards: Analyzing Morbidity and Mortality in Radical Cystectomy across Volume-Based Centers
    3. 13.3
      #0900 Metabolic regulation of metastasis and chemotherapy resistance of bladder cancer by HDAC2-catalyzed ARHGDIB delactylation
    4. 13.4
      #0914 Bladder Cancer Staging with Pre-Cystoscopic mpMRI: A Multicentre Evaluation of the Vesical Imaging Reporting and Data System and Diffusion Kurtosis Imaging
    5. 13.5
      #0933 KAT2A-mediated MECP2 lactylation enhanced malignancy of SMARCB1-deficient bladder cancer via enhancing transcription of ITGB8
    6. 13.6
      #0935 Initial analysis of urinary protein patterns in patients with bladder cancer
    7. 13.7
      #0958 HDACs inhibitor sensitizes the efficacy of cisplatin via H3K18la mediated transcriptional upregulation of DHRS2 in bladder cancer
    8. 13.8
      #0963 Oncological outcomes of partial cystectomy versus radical cystectomy in patients with T2N0M0 bladder cancer: A retrospective study based on the SEER database
    9. 13.9
      #0991 Clinical experience of the orthotopic W-pouch neobladder for urinary diversion post-radical cystectomy in Indonesia: a multicenter study
    10. 13.10
      #1006 IL-22/IL22R1 promotes the progression of bladder transitional cell carcinoma by downregulating EGR1, which is achieved by YBX1 binding to its mRNA
    11. 13.11
      #1016 The Potential of Preoperative LIPI as a Survival Predictor in Bladder Cancer Patients
    12. 13.12
      #1105 Primary Malignant Melanoma of the Bladder Initially Diagnosed as Urothelial Carcinoma: A Case Report
    13. 13.13
      #1108 A 10-year single center experience review of partial cystectomy from 2014 to 2024
  14. 14.
    Free Paper <Podium> (14) Oncology Prostate (D)
    1. 14.1
      #0062 Combining percentage prostate-specific antigen reduction and multiparametric magnetic resonance imaging to reduce unnecessary biopsy after focal therapy with high-intensity focused ultrasound for prostate cancer
    2. 14.2
      #0109 A research of burden and risk factors of prostate diseases from 1990 to 2021 in 21 regions and 204 territories
    3. 14.3
      #0579 Circulating microRNA profiling for prediction of oncological outcomes in prostate cancer patients following radical prostatectomy
    4. 14.4
      #0666 Genitourinary toxicity following radiation therapy is not just about haematuria- lessons from 7 years of a specialist radiation cystitis clinic.
    5. 14.5
      #0668 Intraductal Carcinoma in Localised Prostate Cancer is Over-Represented in Patients with No Intraprostatic Uptake Pattern on PSMA PET
    6. 14.6
      #0676 Reevaluating Role of Vitamin D in Prostate Cancer Pathology: The Impact of MRI-Guided Staging
    7. 14.7
      #0684 Outcomes of Treatment for Localized Prostate Cancer in a Single Institution: Comparison of Radical Prostatectomy and Radiation Therapy Using Inverse Probability of Treatment Weighting (IPTW) Analysis
    8. 14.8
      #0704 Enhancer transcription profiling reveals an enhancer RNA-driven ferroptosis and new therapeutic opportunities in prostate cancer
    9. 14.9
      #0711 Discovery and Validation of Nitroolefin-Based Covalent GPX4 Inhibitors for Inducing Ferroptosis in Prostate Cancer
    10. 14.10
      #0776 Accuracy of Targeted Transrectal Ultrasound Prostate Biopsies
    11. 14.11
      #0816 A comparison between the Australian Cancer Council optimal care pathway for men with prostate cancer and the actual care in a public tertiary centre in Australia
    12. 14.12
      #0834 The Role of 18F PSMA-1007 PET/CT in the Staging and Detection of Recurrence of Prostate Cancer. A Scoping Review.
    13. 14.13
      #1096 High-Grade Undifferentiated Prostate Malignancy in a Young Aboriginal Male: A Case Report
    14. 14.14
      #1098 Hereditary Prostate Cancer: A Case Report of a Cancer Pedigree
    15. 14.15
      #1109 Prevalence of prostate cancer among men undergoing TRUS guided prostatic biopsies, with correlation of serum PSA levels and distribution of Gleason grade groups: A single tertiary care centre experience.
  15. 15.
    Free Paper <Podium> (15) Functional Urology (A)
    1. 15.1
      #0027 Temporal trends in the management of urethral stricture disease in Australia over the 21st century
    2. 15.2
      #0029 Current Australian management trend of male stress incontinence of the 21st century
    3. 15.3
      #0122 The efficacy and safety of sacral neuromodulation with variable frequency stimulation mode compared with constant frequency stimulation mode in the treatment of refractory lower urinary tract dysfunction - a multicenter, prospective, randomized, do
    4. 15.4
      #0123 Optimization of Sacral Neuromodulation Therapy: Clinical Outcomes and Patient Suitability Exploration of Variable Frequency Mode: A prospective multi-center study
    5. 15.5
      #0124 An investigation into the relationship between program control frequency and satisfaction assessment subsequent to sacral neuromodulation, devising an optimal selection of programming control mode for patients
    6. 15.6
      #0204 Multichannel Urodynamic Study for Prediction in Initial Trial Without Catheter Failure After Prostate Deobstruction Surgery
    7. 15.7
      #0223 Linking LUTS and heart health: exploring the cardiac implications of urinary symptoms
    8. 15.8
      #0223 Linking LUTS and heart health: exploring the cardiac implications of urinary symptoms
    9. 15.9
      #0296 A Novel Approach to Bladder Dysfunction induced by Bladder Outlet Obstruction: Low-Intensity Extracorporeal Shock Wave Therapy Promotes Bladder Regeneration
    10. 15.10
      #0318 Skin Sympathetic Nerve Activity as a Potential Diagnostic Biomarker for Differentiating Detrusor Overactivity, Hypersensitive Bladder, and Bladder Pain Syndrome
    11. 15.11
      #0621 Optimal duration of hydrodistension for symptomatic treatment of interstitial cystitis: A systematic review and meta-analysis
    12. 15.12
      #0714 Predictors of Progression to Alternate 3rd Line Overactive Bladder Treatment Following PTNS.
    13. 15.13
      #0730 Treatment Outcomes of Patients with Hunner’s Interstitial Cystitis Who Received Augmentation Enterocystoplasty or Bladder-Preserving Therapy
    14. 15.14
      #0775 Urethral stricture recurrence after urethroplasty: an Australian multi-institution, single surgeon series
    15. 15.15
      #1277 Minimally Invasive (Robotic vs 2D vs 3D Laparoscopic) Pyeloplasty: Experience at a Tertiary Care Centre
    16. 15.16
      #1292 Management for Long Segment Stricture: A Systematic Review and Meta-Analysis
  16. 16.
    Free Paper <Podium> (16) Andrology (A) & Novel Advance (A)
    1. 16.1
      #0128 Blood Metabolites as Mediators in Erectile Dysfunction: Insights from a Multi-Center Proteomics and Genetic Study
    2. 16.2
      #0147 EFFICACY OF PRP INTERVENTION ON POST CAVERNOUS NERVE INJURY-INDUCED ERECTILE DYSFUNCTION : META-ANALYSIS OF IN VIVO STUDY
    3. 16.3
      #0306 Decreased Penile Hemodynamics Correspond with the Severity of Chronic Kidney Disease in Non-Diabetic Men with Erectile Dysfunction
    4. 16.4
      #0329 Comparative Study on Erectile Function in Patients with Benign Prostatic Hyperplasia and Prostate Cancer
    5. 16.5
      #0354 Inflatable Penile Prosthesis Mechanical Failure Incidence and Pattern: A Single Australian Centre Experience
    6. 16.6
      #0365 A Potential Visual Indicator of Early Microvascular Damage in Patients with Erectile Dysfunction
    7. 16.7
      #0388 Optimizing Therapeutic Parameters for Low-Intensity Shockwave Therapy in Erectile Dysfunction—A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    8. 16.8
      #0571 Retrospective study on the treatment of penile curvature by penile plication combined with superficial suspensory ligament release
    9. 16.9
      #0627 The risk factors and comorbidities associated with premature ejaculation in young men
    10. 16.10
      #0699 Clinical study on the effect of corrective treatment and related factors in patients with penile curvature deformity
    11. 16.11
      #0879 Integrating Erection Restoration and Factual Penile Enhancement Through a Revolutionary Fibrovascular Approach
    12. 16.12
      #1224 Penile veno-occlusive mechanism occurs at the cavernosal membrane
    13. 16.13
      #1227 An ambulatory emergent physiological approach for glans enhancement
    14. 16.14
      #1286 Efficacy of right hypogastric nerve excision, bulbospongiosus cutting and frenular delta excision (Alaa Aglan (7) operation)
    15. 16.15
      #1411 A randomised controlled trial investigating the feasibility of electroacupuncture in the treatment of erectile dysfunction after robotic assisted laparoscopic prostatectomy.
  17. 17.
    Free Paper <Podium> (17) Oncology Prostate (E)
    1. 17.1
      #0049 Sexual Activity Patterns and Prostate Cancer Incidence: a large population-based prospective cohort study
    2. 17.2
      #0079 Robot-assisted laparoscopic transvesical radical prostatectomy in the treatment of locally advanced prostate cancer: a single-center experience
    3. 17.3
      #0465 Impact of Preexisting Cardiovascular Risk on MACE and Composite Events in Prostate Cancer Patients Treated with Enzalutamide or Abiraterone: A Nationwide Cohort Study Using the Taiwan NHIRD
    4. 17.4
      #0882 Redefining Prostate Cancer Screening: Unlocking the Potential of the Free-to-Total PSA Ratio in Men with Low PSA
    5. 17.5
      #0913 Index and Composite Biopsy ISUP Grade Group: Implications for Prediction of Radical Prostatectomy Outcomes and Biochemical Recurrence in Localised Prostate Cancer
    6. 17.6
      #0955 Australian, multi-centre assessment of Focal Laser Ablation with ProFocal® in Localised Prostate Cancer
    7. 17.7
      #0962 Influence of Discrepancies Between Magnetic Resonance Imaging and Ultrasound Volume Assessments on Prostate Fusion Biopsy Results
    8. 17.8
      #0969 Outcomes of focal laser ablation (ProFocal®) treatment in clinically localised prostate cancer: a stratified analysis by tumour anatomical location
    9. 17.9
      #0970 Oncological and functional outcomes of apical prostate cancers treated with focal laser ablation (ProFocal®)
    10. 17.10
      #0981 Primary Prostatic Signet Ring Cell Carcinoma—Systematic Review
    11. 17.11
      #1024 Comparing accuracy in Multiparametric MRI of prostate and PSMA PET in the detection of Prostate Cancer and Correlation with Radical Prostatectomy
    12. 17.12
      #1026 Impact of lesion zonal involvement on MRI and PSMA PET Accuracy in Prostate Cancer Diagnosis: A biobot biopsy Dataset analysis
    13. 17.13
      #1028 A Biobot-guided biopsy dataset analysis of the influence of Prostate Volume on MRI Lesion Detection and ISUP Grading Accuracy in Prostate Cancer
    14. 17.14
      #1031 Suicide Risk in Prostate Cancer Patients: Epidemiological Trends and a Predictive Modeling
    15. 17.15
      #1343 Evaluating PI-RADS mpMRI Diagnostic Accuracy Using Transperineal and TRUS Biopsy Histology: Are We Detecting Every Clinically Significant Cancer?
  18. 18.
    Free Paper <Podium> (18) Oncology Bladder UTUC (D) & Functional Urology (B)
    1. 18.1
      #0533 Enhanced Tumor Suppressive Effect of Combining Vorinostat with Cyproheptadine and Their Conjugation Derivatives in Bladder Cancer
    2. 18.2
      #1119 Analysis of Clinical Presentation and Videourodynamic parameter in Female Patients with Dysfunctional Voiding
    3. 18.3
      #1200 Comparing CxBladder Monitor to urine cytology as an adjunct to flexible cystoscopy for enhanced surveillance in non-muscle invasive bladder cancer (NMIBC)
    4. 18.4
      #1242 A Prospective, Observational study to determine the impact of urinary incontinence among pre & post-menopausal women-Questionnaire based study.
    5. 18.5
      #1296 Comparison of outcome of autologous fascia mid urethral sling between retropubic and transobturator ways in patients with stress urinary incontinence
    6. 18.6
      #1304 BCG response in primary and metachronous non-muscle invasive bladder cancer following prior upper tract urothelial cancer: A systematic review and meta-analysis
    7. 18.7
      #1327 Development of a preoperative predictive model for two-year disease recurrence in upper tract urothelial carcinoma after radical nephroureterectomy with bladder cuff excision
    8. 18.8
      #1335 Gut Microbiota Affects the Efficacy of Neoadjuvant Chemotherapy Combined with Immunotherapy in Muscle-Invasive Bladder Cancer
    9. 18.9
      #1347 ONCOLOGICAL OUTCOMES AFTER RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA
    10. 18.10
      #1362 Complete Urinary Tract Extirpation (CUTE) in BK virus-induced urothelial cancer: A limited review of cases at a single institution
    11. 18.11
      #1363 Perioperative Naloxegol use in prevention of post-operative ileus in open radical cystectomy
    12. 18.12
      #1393 Suppression of ferroptosis through the SLC7A11/GPX4 axis drives chemotherapy resistance of bladder cancer
    13. 18.13
      #1404 Association Between PM2.5 Exposure and Disease Outcomes of Upper Tract Urothelial Carcinoma: A Multicenter Study by the Taiwan UTUC Collaboration Group
    14. 18.14
      #1465 Real-World Experience of Enfortumab Vedotin for Metastatic Urothelial Carcinoma
    15. 18.15
      #1512 In-vivo Fibreoptic Raman Spectroscopy for Rapid Bladder Cancer Diagnosis
  19. 19.
    Free Paper <Podium> (19) Functional Urology (C)
    1. 19.1
      #0166 Assessing the relationships of 1,400 blood metabolites with urinary incontinence: a Mendelian randomization study
    2. 19.2
      #0239 Perioperative Electrophysiological Therapy Reduces the Incidence of Postoperative Urinary Incontinence after Radical Prostatectomy: A Prospective Observational Study
    3. 19.3
      #0501 Management of the neurogenic lower urinary tract following spinal cord injury: A literature review
    4. 19.4
      #0607 Videourodynamic predictive factors of urological complications in patients with chronic spinal cord injury and detrusor sphincter dyssynergia
    5. 19.5
      #0651 Satisfaction with Bladder Management in Community-Dwelling Patients with Chronic Spinal Cord Injury
    6. 19.6
      #0656 Allium® metal ureteric stent (AMUS) for ureteral stricture after renal transplantation: The first case report in Taiwan
    7. 19.7
      #0890 Prevalence of Lower Urinary Tract Symptoms in Individuals with Sarcopenia: A Systematic Review and Meta-Analysis
    8. 19.8
      #0896 How Brain Tumor impacts Neurogenic Lower Urinary Tract Dysfunction
    9. 19.9
      #0978 Transcutaneous Tibial Nerve Stimulation as an Adjunct to Pharmacologic Therapy for Overactive Bladder: A Retrospective Comparative Study
    10. 19.10
      #1015 Can Stem Cell Therapy Revolutionize the Treatment of Overactive Bladder? A Systematic Review of Current and Future Potential
    11. 19.11
      #1106 Predictors of Persistent LUTS Following Bladder Trauma: a single tertiary centre experience
    12. 19.12
      #1268 Unveiling Urinary Tract Infection Risks in Chronic Spinal Cord Injury: A Longitudinal Analysis of Bladder Management Impacts
    13. 19.13
      #1376 Cost-Effectiveness of Treatment for Overactive Bladder Syndrome: A Focus on Third Line Therapies
    14. 19.14
      #1382 Determinants of UTI-Related Hospital Admissions in Spinal Cord Injury Patients: The Impact of Injury Characteristics and Bladder Management
    15. 19.15
      #1507 The Gore Test: Tackling the diagnostic challenge of intraprostatic ductal urinary reflux in men with Chronic Pelvic Pain Syndrome
  20. 20.
    Free Paper <Podium> (20) Oncology RCC (B)
    1. 20.1
      #0781 Evaluating plasma succinyl-adenosine as a diagnostic biomarker for fumarate hydratase-deficient renal cell carcinoma
    2. 20.2
      #0793 SREBP1 Induces Resistance to HIF-2α antagonist in Clear Cell Renal Cell Carcinoma
    3. 20.3
      #0847 Computed Tomography Radiomics-Derived Nomogram for Predicting Early Renal Function Decline after Partial Nephrectomy in Renal Cell Carcinoma: A Multicenter Retrospective Development/Validation Study
    4. 20.4
      #0905 Postoperative Spleen Volume Changes as a Prognostic Indicator in Localized Renal Cell Carcinoma
    5. 20.5
      #0906 Comparative analysis of Robotic vs 3D-Laparoscopic Partial Nephrectomy in Renal Tumors
    6. 20.6
      #1005 Pathological and Clinical Outcomes in an Active Surveillance and Intervention Cohort of Radiographically Renal Cysts
    7. 20.7
      #1132 cT1b Renal Cell Carcinomas can be Safely Treated with Robot-Assisted Partial Nephrectomy
    8. 20.8
      #1236 Managing High-Complexity Renal Tumors (RNS ≥10) with Robotic-Assisted Partial Nephrectomy: Vietnamese Experience
    9. 20.9
      #1280 Robotic Retrohepatic Inferior Vena Cava Thrombectomy Using the Caudate Lobectomy Technique: Indications and Initial Outcomes
    10. 20.10
      #1319 The Outcomes of SGLT-2 Inhibitor Utilization in Patients with Non-metastatic Renal Cell Carcinomas and Type 2 Diabetes Mellitus
    11. 20.11
      #1443 A Comparative Analysis of Robotic vs Laparoscopic Partial Nephrectomy for a Complex Renal Mass (R.E.N.A.L. Score ≥ 10); Single surgeon study
    12. 20.12
      #1447 Management of complex Large renal masses (>70mm) by a single surgeon; Robotic and Laparoscopic partial nephrectomy
    13. 20.13
      #1478 INITIAL EXPERIENCE IN ROBOT – ASSISTED RADICAL NEPHRECTMOMY AND INFERIOR VENA CAVA THROMBECTOMY
    14. 20.14
      #1489 Vitexin as a promising new approach to overcome drug resistance in renal cell carcinoma treatment
  21. 21.
    Free Paper <Podium> (21) BPH & Novel Advances (B)
    1. 21.1
      #0385 REZUM as treatment for BPH in Australian Public hospitals. A single centre retrospective analysis.
    2. 21.2
      #0457 Aquablation for Benign Prostatic Hyperplasia: Evaluating Efficacy, Safety, and the Learning Curve in a Taiwanese Cohort
    3. 21.3
      #0484 Evaluation and validation of a disposable uroflowmeter - "P-Flow"
    4. 21.4
      #0725 A novel vaginal prolapse repair technique: using autologous vaginal mucosal grafts
    5. 21.5
      #0726 One-Year Follow-Up of a Randomized Prospective Clinical Trial Comparing Holmium MOSESTM vs. Thulium Fiber Laser Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia
    6. 21.6
      #0738 Randomized Controlled Trial: Effectiveness of Urethral Dilatation in Preventing Stricture Formation Post-Transurethral Resection of the Prostate (TURP)
    7. 21.7
      #0778 Optimizing Patient Selection for Minimally Invasive Surgical Therapies in Male LUTS: The Role of Videourodynamic Study
    8. 21.8
      #0836 The Impact of MISTs on Australia BPO Surgical Trends.
    9. 21.9
      #0987 Clinical Outcomes of Contact Laser Vaporization of the Prostate (CVP) : Insights from Pressure Flow Studies
    10. 21.10
      #1025 Outcomes of Rezum Water Vapor Therapy for Treatment of Benign Prostatic Hyperplasia: Initial Experience from the Developing World
    11. 21.11
      #1306 1-Monopalmitin inhibits benign prostatic hyperplasia by suppressing endoplasmic reticulum stress and androgen receptor
    12. 21.12
      #1337 Prostate Artery Embolisation safety and efficacy: an Australian multi-centre review
    13. 21.13
      #1394 Evaluating the learning curves and clinical outcomes of prostatic urethral lift performed by experienced versus naive urologists
    14. 21.14
      #1438 Comparison of Laparoscopic Pectopexy and Sacrocolpopexy in Apical Prolapse Management
    15. 21.15
      #1439 Innovative Approach in Laparoscopic Transvesical Repair of Vesicovaginal Fistulas: A Focus on T Cystostomy
  22. 22.
    Free Paper <Podium> (22) Oncology Prostate (F)
    1. 22.1
      #0740 Autologous Dendritic Cell Vaccination as Add-On Therapy Improves Overall Survival in Stage IV Prostate Cancer: A Retrospective Matched Cohort Study
    2. 22.2
      #0786 PSMA-Targeted Self-Assembled DNA Tetrahedral Nanoprobes for In Vivo Imaging: A Novel Strategy for Non-Invasive Diagnosis and Metastasis Monitoring in Prostate Cancer
    3. 22.3
      #0851 SPP1+ Macrophage/FAP+ Fibroblast Crosstalk Predicts Disease Progression and Immunosuppressive Niche in Prostate Cancer
    4. 22.4
      #1114 Prostate Cancer Management Across Asia and Oceania: Insights from a Multi-Country UAA Survey
    5. 22.5
      #1117 Gleason 6 cancer - time for a rebrand?
    6. 22.6
      #1151 Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer Patients: A Prospective Study
    7. 22.7
      #1166 Diagnostic efficacy of 68Ga-PSMA-PET/CT scan as a single staging modality in prostate cancer: Evidence from a tertiary healthcare centre
    8. 22.8
      #1168 Prostate Cancer: A Novel MRI-Based Predictive Model Co-Registered with Whole-Mount Pathology
    9. 22.9
      #1186 Analysis of Time to Prostate-specific antigen (PSA) Nadir After Radical Prostatectomy In Taiwan
    10. 22.10
      #1233 Comparison of Ga68 PSMA-PET/MRI Fusion Based Cognitive-Targeted versus MRI-TRUS Fusion Biopsy for the Diagnosis of Prostate Cancer- A Pilot Study
    11. 22.11
      #1278 PREDICTIVE FACTORS OF PATHOLOGICAL UPGRADING IN INDIAN PATIENTS WITH GLEASON SCORE 3+4 PROSTATE CANCER: WHEN TO OFFER ACTIVE SURVEILLANCE?
    12. 22.12
      #1290 Targeted Versus Targeted Plus Random Transperineal MR/US Prostate Biopsy in patients with a single lesion on MRI: Is There Added Value?
    13. 22.13
      #1322 Deintensification of androgen receptor pathway inhibitor in metastatic hormone-sensitive prostate cancer: an exploratory study of survival outcomes and predictive factors
    14. 22.14
      #1338 Transperineal Prostate Biopsy Using Freehand Technique Under Local Anaesthetic: A Systematic Review and Meta-analysis
    15. 22.15
      #1372 Improved CSPCa Detection Rate by MRI-TRUS Fusion Biopsy Compared to Conventional Biopsy: A Large Single-Center Experience
  23. 23.
    Free Paper <Podium> (23) Novel Advances (C)
    1. 23.1
      #0087 Holographic Imaging-assisted Robotic Partial Adrenalectomy for Adrenal Tumor: Technique and Outcomes from a Single Center
    2. 23.2
      #0432 The first assistant puts on a virtual reality headset (Meta Quest) to assist with da Vinci robotic surgery
    3. 23.3
      #0827 Antegrade stent removal technique
    4. 23.4
      #0880 Seeing Beyond the Surface: The Transformative Role of Endoluminal Ultrasound and Optical Coherence Tomography in Ureteric Diagnostics
    5. 23.5
      #0927 Comparison of Perioperative Outcomes in Robotic vs. Open IVC Thrombectomy in Locally Advanced Renal Cell Carcinoma: A Single-Center Experience
    6. 23.6
      #0960 Cystoscopic application of a haemostatic agent - RADA16 Self-assembling peptide (Purastat®) for refractory haematuria from radiation cystitis: a novel surgical technique.
    7. 23.7
      #1178 Unveiling the role of trace elements in renal stone disease: A case-control study
    8. 23.8
      #1201 Clinical Impact of Intrarenal Pressure Monitoring and Mechanical Performance of the LithoVue™ Elite Flexible Ureteroscope
    9. 23.9
      #1274 Knowledge Mapping of Telemedicine in Urology in the past 20 years: A Bibliometric Analysis (2004-2024)
    10. 23.10
      #1425 Percutaneous Foam Sclerotherapy for Simple Renal Cysts: Prospective single centre experience
  24. 24.
    Free Paper <Podium> (24) Functional Urology (D)
    1. 24.1
      #0028 21st century management trend of female stress incontinence in Australia
    2. 24.2
      #0125 Differences in Functional Brain Regions in Patients with Interstitial Cystitis/Painful Bladder Syndrome: A Resting-State Functional Magnetic Resonance Imaging Study
    3. 24.3
      #0380 Examination of the Frequency and Associated Risk Factors of Urinary Tract Infections Following Total Hysterectomy in Patients with Benign Uterine Conditions
    4. 24.4
      #0466 Initial Experience of Robotic-Assisted Laparoscopic Sacrocolpopexy (RASC) Using the Hugo RAS System
    5. 24.5
      #0686 One-Stage vs. Two-Stage Urethroplasty in Adults with Post-Hypospadias Strictures: A Systematic Review and Meta-Analysis
    6. 24.6
      #0710 Dr. Why I am still not Dry --- Urodynamic changes after successful VVF repair
    7. 24.7
      #0744 Clinical Efficacy of Bladder Neck Injection of Botulinum Toxin A in Treatment of Neurogenic and Non-neurogenic Voiding Dysfunction due to Bladder Neck Dysfunction
    8. 24.8
      #0897 Use of Clinical Characteristics, Cystoscopic Findings, and Urine Biomarkers in Predicting Satisfactory Treatment Outcome in Women with Interstitial Cystitis/ Bladder Pain Syndrome
    9. 24.9
      #0902 Prediction of Bladder Outlet Obstruction in Male Patients with Lower Urinary Tract Symptoms Based on Symptom Scores and Noninvasive Office-based Diagnostic Tools
    10. 24.10
      #0950 Recovery of Urinary Continence After Neoadjuvant Hormonal Therapy Plus Radical Prostatectomy: A Multicenter Retro-prospective Cohort Study with Propensity Score Matching
    11. 24.11
      #0995 Comparison of stricture recurrence post-urethroplasty in obliterative, near- and non-obliterative urethral strictures in adult males.
    12. 24.12
      #0999 Association between smoking status and stricture recurrence post-urethroplasty for urethral stricture disease in adult males.
    13. 24.13
      #1000 Patterns of stricture recurrence post-urethroplasty stratified by stricture aetiology, segment and length in adult males.
    14. 24.14
      #1457 Advancing Pelvic Reconstructive Surgery: Comparative Genomic, Histological and Biomechanical Assessment of Human Fascia Lata versus Polypropylene Mesh
    15. 24.15
      #1459 Engineering Biocompatible Solutions for POP: eMSC-Seeded and Plasma-Treated Scaffolds
  25. 25.
    Free Paper <Podium> (25) Oncology Prostate (F)
    1. 25.1
      #0854 PRMT2/RIPK3/MLKL Axis Regulates CXCL5 Secretion to Suppress MDSC Recruitment in Prostate Cancer
    2. 25.2
      #1287 Efficacy of right hypogastric nerve excision, selective neurectomy around penis and frenular delta excision (Alaa Aglan (8) operation)
    3. 25.3
      #1288 Efficacy of right hypogastric nerve excision, bulbospongiosus muscles cutting, frenular delta excision and penis nerve neurectomy (Alaa Aglan (9) operation)
    4. 25.4
      #1378 Retrospective Review of the Diagnostic Performance of PSMA PET/CT versus mpMRI in the T staging of Clinically Significant Prostate Cancer
    5. 25.5
      #1414 Diagnostic Accuracy of 68Ga-PSMA PET/CT to Identify Residual Prostate Cancer Following Focal Therapy with Irreversible Electroporation for Localised Prostate Cancer: A Prospective Study
    6. 25.6
      #1430 Declining use of pelvic lymphadenectomy despite increase in number of prostatectomies performed: national population data over 24 years
    7. 25.7
      #1436 Safety and efficacy of concurrent robotic prostatectomy and inguinal hernia repair: A systematic review and meta-analysis.
    8. 25.8
      #1450 ADDITIVE VALUE OF PROSTATIC ZONE AND PSA DENSITY IN PIRADS FOR PREDICTING ACCURACY OF CLINICALLY SIGNIFICANT PROSTATE CANCER
    9. 25.9
      #1451 Median 7-year outcomes of primary focal irreversible electroporation for localised prostate cancer
    10. 25.10
      #1471 Whole Genome Sequencing as a Comprehensive Tool for Diagnosis, Therapeutic Guidance, and Prognosis of Prostate Cancer to Advance Personalized Medicine in Indonesia
    11. 25.11
      #1472 Oncological and functional outcome of repeat irreversible electroporation for recurrent prostate cancer after primary electroporation
    12. 25.12
      #1483 False Positive PSMA PET/CTs following irreversible electroporation: a case series
    13. 25.13
      #1494 The survival outcome of radical prostatectomy for localized prostate cancer with positive lymph nodes
  26. 26.
    Free Paper <Podium> (26) Oncology Miscellaneous & Endourology (C)
    1. 26.1
      #0058 Silent Protein, Powerful Weapon: CLDN6 and the Immunotherapeutic Breakthrough in Germ Cell Testicular Carcinoma: A Systematic Review and Meta Analysis
    2. 26.2
      #0145 Outcomes of Testicular Germ Cell Tumors (TGCTs): A Single-Center Study from Oman
    3. 26.3
      #0419 Metastatic SCC of Inguinal lymph node- A rare case of carcinoma of unknown primary.
    4. 26.4
      #0643 Incidental finding of Metastasis cancer in Inguinal Hernia Sac;10-year experience of Taipei City Hospital
    5. 26.5
      #0773 Causal Association Between Body Mass Index and Kidney Stone Disease in Taiwanese: A Mendelian Randomization Study
    6. 26.6
      #0907 SPRR1B+ Epithelial-like endothelial cells promoting the malignant progression of Penile squamous cell carcinoma
    7. 26.7
      #0912 Endoscopic Enucleation of the Prostate for Benign Prostatic Hyperplasia: Comparable Efficacy Across All Prostate Sizes
    8. 26.8
      #0915 Primary Testicular Lymphoblastic Lymphoma: A Case Report and Literature Review of Diagnosis and Staging Investigations, Treatment, and Prognosis
    9. 26.9
      #0938 Outcomes and Predictors of Complications in Patients Undergoing Laparoscopic Ureterolithotomy: A Single-Center Retrospective Analysis
    10. 26.10
      #0939 A 40-Year Comparative Study: Temporal trends of Male Primary Urethral Carcinoma: Potential Impact of Reduced Arsenic Exposure in Taiwan versus the USA
    11. 26.11
      #1032 Comparison of traditional and flexible suctioning ureteral access sheath combined with flexible ureteroscope to treat upper tract calculi
    12. 26.12
      #1099 Testicular Mesothelioma with Hepatic Metastases in a 91-Year-Old Male: A Rare Presentation
    13. 26.13
      #1104 Predictive analysis of new chronic renal impairment after pelvic exenteration in an Australian quaternary centre
    14. 26.14
      #1496 From Teratoma to Triumph : Revisiting the Paradox of Growing Teratoma Syndrome
  27. 27.
    Free Paper <Podium> (27) Andrology (D)
    1. 27.1
      #232 NEW INSIGHTS ABOUT THE ROLE OF FSH THERAPY IN IDIOPATHIC MALE INFERTILITY
    2. 27.2
      #426 The molecular mechanism by which METTL3-mediated m6A methylation modification activates MAT2A to drive the invasion, migration, and cisplatin resistance of bladder cancer
    3. 27.3
      #683 Testicular Sperm Extraction for Patients with Permanent Azoospermia After Chemotherapy: A Systematic Review and Meta-Analysis
    4. 27.4
      #764 From Microbes to Motility: Unlocking the Gut-Testis Axis for Reshaping Male Infertility
    5. 27.5
      #848 A Novel Therapeutic Strategy for Late-Onset Hypogonadism: Targeted ApoE Delivery to Leydig Cells for Cholesterol Homeostasis Restoration
    6. 27.6
      #992 Short and Long-Term Efficacy, Safety, and Usability of Novoglan for Adult Phimosis: Clinical Trial Data vs. Real-World Outcomes from 811 Patients
    7. 27.7
      #1042 Comparison of urinary continence rates between three different vesicourethral anastomosis procedures in robotic-assisted radical prostatectomy: Simple anastomosis with barbed suture, tennis-racket bladder reconstruction, and Van Velthoven anastomos
    8. 27.8
      #1084 Urethral catheterisation device (UCD®) for difficult catheter insertion in the Emergency Department
    9. 27.9
      #1206 Testicular Tissue Touch Print Smear for Infertile Males: Values Beyond Diagnosis
    10. 27.10
      #1328 Evaluating the Placebo Effect in Regenerative Therapy Trials for Erectile Dysfunction: A Systematic Review and Meta-analysis
    11. 27.11
      #1422 Can Preoperative Shear Wave Elastography Predict the Outcomes of Varicocelectomy in Relation to Semen Parameters and Sperm DNA Fragmentation Index?: Prospective single centre experience
    12. 27.12
      #1442 Physiological Approach for penile venous stripping and varicocelectomy
  28. 28.
    Free Paper <Moderated Poster> (1) Oncology Bladder UTUC (A)
    1. 28.1
      #0133 Predictors of Patient Anxiety during Flexible Cystoscopy: A Single Tertiary Centre Experience
    2. 28.2
      #0142 Potential of APOBEC3B as a therapeutic target and its role in bladder cancer onset and progression
    3. 28.3
      #0382 Upper Tract Urothelial Carcinoma with an Uncommon Duodenal Metastasis Complicated by Duodenal Stenosis: A Case Study and Literature Review
    4. 28.4
      #0405 Gender Differences in the Oncology Outcome of Upper Tract Urothelial Carcinoma (UTUC)
    5. 28.5
      #0441 Survival rate and prognostic factors of ureteral cancer after surgery
    6. 28.6
      #0476 Evaluation of the efficacy and safety of antibody-drug conjugates in the treatment of advanced urothelial carcinoma: an updated meta-analysis
    7. 28.7
      #0564 Combination therapy of doxorubicin and vorinostat produces potential synergistic effect in patients with urothelial carcinoma
    8. 28.8
      #0574 Prognostic Factors for Recurrence, Progression, and Multiple Recurrences of Non-Muscle-Invasive Bladder Cancer in Eastern Taiwan
    9. 28.9
      #0652 Real world study of enfortumab vedotin (EV) combine pembrolizumab treatment in locally advance or metastasis urothelial carcinoma
    10. 28.10
      #0741 Comparing low-dose and full-dose intravesical Sii-Onco BCG in patients with intermediate and high risk NMIBC: A prospective randomised study
    11. 28.11
      #0774 OIP5-AS1 modulates cell proliferation, migration and invasion through ADAM9 via targeting miR-30c-5p in upper tract urothelial carcinoma
    12. 28.12
      #0872 Intra-diverticular bladder urothelial carcinoma: Two rare cases and literature review
    13. 28.13
      #0920 Increased Splenic Volume With Low Lymphocyte Percentage Predict Poor Oncologic Outcomes in Upper Tract Urothelial Carcinoma
    14. 28.14
      #1073 Optimizing Urothelial Carcinoma Surveillance in Patients with Lynch Syndrome: A Role for Annual Cxbladder Testing?
    15. 28.15
      #1118 Optimizing Perioperative Chemotherapy in Upper Tract Urothelial Carcinoma: A Real-World TriNetx Analysis of Neoadjuvant vs. Adjuvant Approaches
    16. 28.16
      #1123 Real world treatment outcomes for metastatic urothelial carcinoma
    17. 28.17
      #1127 Urothelial Cancer Screening in Lynch Syndrome: Addressing a Critical Gap in Early Detection
    18. 28.18
      #1143 Analysis of Neoadjuvant Chemoimmunotherapy in Muscle-Invasive Bladder Cancer
    19. 28.19
      #1173 Comparison of Effect of Pterostilbene on Apoptosis of Bladder Cancer Cells at Different Stages
  29. 29.
    Free Paper <Moderated Poster> (2) Endourology (A)
    1. 29.1
      #0167 Association of insulin resistance indices with kidney stones and their recurrence in a non-diabetic population: an analysis based on NHANES data from 2007-2018
    2. 29.2
      #0372 Increased Risk of Urolithiasis in Patients with Primary Aldosteronism: A Large-Scale Retrospective Cohort Study
    3. 29.3
      #0469 Grape Seed Polyphenolic Extracts and Urinary pH Modulation in Nephrolithiasis: A Systematic Review and Meta-Analysis
    4. 29.4
      #0475 Comparison of Different Surgical Approaches for Ureteropelvic Junction Stones: A Five-Year Single Center Experience
    5. 29.5
      #0592 Association of Obesity with Renal Function Improvement Following Nephrolithiasis Surgery
    6. 29.6
      #0694 The efficacy of the attenuation value of bladder urine on non-contrast CT for predicting urine culture positivity
    7. 29.7
      #0712 Can Machine Learning Revolutionize Post-RIRS Urosepsis Prediction? A Single-Center Study
    8. 29.8
      #0713 The association between urate-lowering therapy and surgical intervention for urolithiasis among gout patients — A Nationwide Cohort Study.
    9. 29.9
      #0742 Blood diamond: post renal trauma de novo renal stones - a case report and literature review
    10. 29.10
      #0752 Genetic Risk and Biochemical Signatures for Urolithiasis Risk Prediction: A Cross-cohort Study in the United Kingdom and Hong Kong
    11. 29.11
      #0754 National study of urolithiasis in the United states: an in-depth analysis based on the GBD study 2021
    12. 29.12
      #0759 Single Tract miniPCNL in Complete Staghorn Stones: Outcomes and Factors Associated with Stone-Free Rate
    13. 29.13
      #0783 Propensity Score Matching of Suction vs non-suction Mini Percutaneous Nephrolithotomy (mPCNL) 30 day outcomes from a real world multicentre prospective study. An EAU Endourology and AUSET Collaboration
    14. 29.14
      #0965 Real-world Patient-Specific Factors Predisposing to Encrustation in Percutaneous Nephrostomy
    15. 29.15
      #1050 Magnetic Stents versus Stents on Extraction Strings: A retrospective review of post-ureteroscopy complications
    16. 29.16
      #1203 Does the Ratio of Endoscope-Sheath to Suction Sheath Diameter Affect Stone Clearance in Retrograde Intrarenal Surgery? A Comparative Analysis
    17. 29.17
      #1253 Staghorn Uric Acid Nephrolithiasis: Is Oral Chemolysis a Viable Alternative to Surgery?
    18. 29.18
      #1254 Impact of Irrigation Flow Rates on Intrarenal Temperature During Laser Lithotripsy: An Ex Vivo Experimental Model
    19. 29.19
      #1255 Antibiotic Prophylaxis in Endoscopic Stone Surgery for Patients with Bacteriuria: A Risk-Based Approach
  30. 30.
    Free Paper <Moderated Poster> (3) Oncology Prostate
    1. 30.1
      #0024 IL-8/CXCR2 Mediate Lipid Accumulation in Prostate Cancer Microenvironment and reshapes the Tumor Immune Microenvironment
    2. 30.2
      #0091 Assessing the Outcomes of Focal Therapy as the Primary Treatment of Prostate Cancer In Asian Populations: A Comprehensive Systematic Review and Meta-analysis
    3. 30.3
      #0140 Identification of putative prognostic genes associated with neddylation in prostate cancer
    4. 30.4
      #0141 Single-cell and transcriptomic data integrated mendelian randomization study reveals the potential value of prognostic genes associated with mitochondria and programmed cell death in prostate cancer
    5. 30.5
      #0240 Gleason Score Upgrading in Grade Group 1 Prostate Cancer: Insights from a Retrospective Cohort Study
    6. 30.6
      #0346 Enzalutamide (ENZA)±leuprolide (L) in biochemically recurrent (BCR) prostate cancer (PC): EMBARK post hoc analysis of Asia Pacific (APAC) population
    7. 30.7
      #0404 Establishment of Two Cases of PDX from Organoids Derived from CTCs Collected from Prostate Cancer Patient's blood
    8. 30.8
      #0423 Cell-free DNA analysis for precision medicine in metastatic castration-sensitive prostate cancer
    9. 30.9
      #0444 Management of Cardiometabolic Risk in Prostate Cancer: Expert Consensus from Singapore and Malaysia
    10. 30.10
      #0532 Single-Cell RNA Sequencing of Prostate Cancer Reveals Epithelial Cells Characterized by Epithelial-Mesenchymal Transition Associated with Disease Progression in Rare Pathological Types
    11. 30.11
      #0588 Neuregulin-1 Regulation of Cell Proliferation and Survival in Castration-Resistant Prostate Cancer: Implications for Cellular Senescence
    12. 30.12
      #0611 Assessing Biochemical Recurrence After Prostatectomy in Prostate Cancer Patients Using F-18-PSMA-1007 PET: Insights from Our Institute
    13. 30.13
      #0612 Assessing Outcome of Radiotherapy with Concurrent Androgen Deprivation Therapy in Biochemical Recurrence After Prostatectomy Patients Using F-18-PSMA-1007 PET
    14. 30.14
      #0616 Deep response of Apalutamide in high risk mCSPC, CGRD experience
    15. 30.15
      #0673 Algorithmic Prediction of Gleason Score Upgrading in Biopsy 3+3 Prostate Cancer: Insights from a Retrospective Cohort
    16. 30.16
      #0691 Boosting Survival with Cytoreductive Radical Prostatectomy in Metastatic Hormone-Sensitive Prostate Cancer: Insights from a Retrospective Analysis
    17. 30.17
      0745 A Multicenter Analysis of Long-Term Oncological Outcomes Comparing EBRT and HIFU for Prostate Cancer Using IPTW and the Chang Gung Research Database
    18. 30.18
      #0746 Is bone scan necessary of low/very low prostate cancer patients? A retrospective study in Taiwan
    19. 30.19
      #0755 CEMIP and CTCF role in castration-resistant prostate cancer: A novel insight from 3D spheroid model
  31. 31.
    Free Paper <Moderated Poster> (4) Functional Urology
    1. 31.1
      #0143 Current Practice Patterns in the Management of Male Anterior Urethral Strictures: A Nationwide Survey of Japanese Urologists
    2. 31.2
      #0428 The effect of estradiol enhanced autophagy by inhibiting miRNA-200b to alleviate bladder hyperactivity in ovarian hormone deficiency - induced overactive bladder rats
    3. 31.3
      #0558 Assessment of Persistent Hydronephrosis Following Ureteral Reconstruction
    4. 31.4
      #0590 Predictive factors for a successful treatment outcome of multiple platelet-rich plasma injections in men with postprostatectomy urinary incontinence-patient's satisfaction and outcome
    5. 31.5
      #0595 Revealing Distinct Treatment Mechanisms and Outcome Correlations in Patients with Interstitial Cystitis/Bladder Pain Syndrome After Different Bladder Therapies Through Urinary Biomarker Analysis
    6. 31.6
      #0603 Robotic-assisted sacrocolpopexy for pelvic organ prolapse: Functional and QoL Outcomes with up to 10 Years follow-up
    7. 31.7
      #0655 Urethro Rectal Fistula How to Repair
    8. 31.8
      #0658 The short-term outcome of mid-urethral sling surgery for stress urinary incontinence
    9. 31.9
      #0674 Applying K-means Cluster Analysis to Urine Biomarkers in Interstitial Cystitis/ Bladder Pain Syndrome: A New Perspective on Disease Classification
    10. 31.10
      #0728 The efficacy of pelvic floor physiotherapy in functional bladder conditions: a systematic review
    11. 31.11
      #0748 Study on the effectiveness of different pelvic floor muscle training modes on the improvement of urinary incontinence in prostate cancer patients after radical prostatectomy
    12. 31.12
      #0951 The Association Between Sugar-Sweetened Beverage Consumption and Storage Symptoms in Female Lower Urinary Tract Disorders: A Comprehensive Cross-Sectional Analysis Using NHANES Data (2005–2018)
    13. 31.13
      #1093 Nocturia and Mortality: Mediating Roles of Serum Uric Acid and Metabolic Syndrome in a Nationally Representative Cohort
    14. 31.14
      #1171 Using neurogenic bladder dysfunction rat model to evaluate the effect of brevetoxin on detrusor contractility
    15. 31.15
      #1291 Impact of Preoperative Membranous Urethral Length on Continence Outcomes Following Robotic-Assisted Laparoscopic Radical Prostatectomy in Chinese Men
    16. 31.16
      #1497 Laser Welding of Vesicovaginal Fistula-Feasibility and Outcome Analysis
  32. 32.
    Free Paper <Moderated Poster> (5) Oncology: RCC & Miscellaneous
    1. 32.1
      #0376 Exploring the causal relationship between kidney volume and renal disease and renal function: a bidirectional two-sample Mendelian randomization study
    2. 32.2
      #0489 Predictive value of computed tomography-derived adipose tissue parameters for histologic grade and clinical stage in renal cell carcinoma
    3. 32.3
      #0494 MKRN1 as a Tumor Suppressor in Renal Angiomyolipomas: Regulation of ERK/MAPK Pathway
    4. 32.4
      #0591 Radical or Partial Orchiectomy? Operative Considerations for Testicular Tumors
    5. 32.5
      #0646 Investigating the Correlation Between Body Mass Index (BMI) and PDL-1 Expression in Renal Cell Carcinoma (RCC)
    6. 32.6
      #0823 3D Laparoscopy is Better than 2D in Achieving Pentafecta in Nephron-Sparing Surgery for RCC.
    7. 32.7
      #0849 Pentafecta functional results of open, laparoscopic and robot-assisted nephron sparing surgery. Single institution comparative study.
    8. 32.8
      #1076 Primary Ewing’s Sarcoma with Massive IVC Thrombus of Kidney: A Unique Entity
    9. 32.9
      #1107 Comparative Outcomes of First-Line ICI Combination and TKI Monotherapy for Advanced RCC
    10. 32.10
      #1116 Trends in percutaneous renal biopsy for small renal masses in Australia – a 24 year retrospective analysis
    11. 32.11
      #1150 Concurrent Gastrointestinal Stromal Tumor (GIST) and Renal Cell Carcinoma (RCC) in a 72-Year-Old Female: A Case of Presumed Small Bowel Metastasis
    12. 32.12
      #1207 Impact of Robot-Assisted Versus Laparoscopic Approaches on Perioperative Outcomes in Partial Nephrectomy: A Systematic Review and Meta-Analysis
    13. 32.13
      #1237 A Rare Case of Neurilemmoma at the Glans Penis: Comprehensive Clinical and Radiological Evaluation, Surgical Management, and Long-term Follow-up
    14. 32.14
      #1279 ENHANCING SURGICAL PLANNING FOR COMPLEX RENAL TUMORS: A CASE-BASED SURVEY INVESTIGATING THE IMPACT OF 3D RENAL RECONSTRUCTION
    15. 32.15
      #1377 Perioperative outcome of minimally invasive versus open partial nephrectomy of localized renal cell carcinoma - A single centre retrospective 5-year study
    16. 32.16
      #1467 A Rare Case of Intrascrotal Hibernoma Mimicking Well-Differentiated Liposarcoma of the Scrotum: A Case Report
    17. 32.17
      #1487 Percutaneous Ablation for Small Renal Masses: Clinical Outcomes in a Single-Center Cohort
  33. 33.
    Free Paper <Moderated Poster> (6) Pediatric Urology & Infectious Disease
    1. 33.1
      #0158 Re-ablation of the residual posterior urethral valve: a single center retrospective study
    2. 33.2
      #0286 Microbiological characteristics of urosepsis following febrile urinary tract infection in the elderly
    3. 33.3
      #0445 Clostridium butyricum pretreatment alleviates unilateral ureteral obstruction induced renal injury by modulating the gut microbiota-SCFAs-HDACs axis
    4. 33.4
      #0446 Using Compound Chamomile-Lidocaine Gel in Pediatric Circumcision: A Randomized Controlled Trial
    5. 33.5
      #0486 Identifying mortality predictors in Fournier’s gangrene: analysis of 84 patients and three prognostic scoring systems
    6. 33.6
      #0507 A Comparative Study of Pediatric Inguinal Hernia and Hydrocele: Surgical Characteristics and Diagnostic Implications of the Silk Sign
    7. 33.7
      #0870 Efficacy of Proactive Cystoscopic Debris Removal in Reducing Catheter-Associated Urinary Tract Infections and Blockage in Long-Term Indwelling Catheter Users: A Prospective Trial
    8. 33.8
      #1111 Conservative management of a through-and-through gunshot injury of the right kidney – a review of the treatment paradigm
    9. 33.9
      #1139 Scrotal Hematoma Secondary to spermatic cord vessels bleeding Mimicking Testicular Torsion in a Preterm Neonate: A Case Report
    10. 33.10
      #1158 GLANS-MEATUS-SHAFT SCORING AS A PARAMETER IN PREDICTING THE LEVEL OF ACCEPTANCE AND QUALITY OF LIFE OF POST HYPOSPADIAS REPAIR PATIENTS: A SINGLE INSTITUTION REVIEW
    11. 33.11
      #1198 The Deflux Injection Reduced the Incidence of Urinary Tract Infections in Children with Vesicoureteral Reflux
    12. 33.12
      #1211 Melioidosis in the Rain: Environmental Triggers and the Pathophysiology of Prostatic Abscesses
    13. 33.13
      #1364 Comparison of the efficacy and safety of extracorporeal shock wave lithotripsy and mini percutaneous nephrolithotomy in treating renal pelvis calculus in infants
    14. 33.14
      #1365 Efficacy And Safety Of Mini Percutaneous Nephrolithotomy And Open Pyelolithotomy For Renal Stones In Pediatric Population
    15. 33.15
      #1366 The Effectiveness Of Open Anderson-Hynes Pyeloplasty For Congenital Unilateral Uretero-Pelvic Junction Obstruction In School Going Children
    16. 33.16
      #1468 Idiopathic bilateral renal hemorrhage: Wunderlich Syndrome: A Case report
  34. 34.
    Free Paper <Moderated Poster> (7) Andrology & BPH
    1. 34.1
      #0244 Comparing TURP and HoLEP for Benign Prostatic Hyperplasia Treatment: A Meta-Analysis Using Common Data Model Data from Korean Hospitals
    2. 34.2
      #0290 Lactiplantibacillus plantarum 1008 advances testosterone, spermatogenesis and cognitive activity in aged male mice with high-fat diet-induced obesity
    3. 34.3
      #0473 Study on the core prescription of traditional Chinese medicine in the treatment of idiopathic oligoasthenospermia
    4. 34.4
      #0479 Beyond Prostate Size: Intravesical Prostatic Protrusion Predicts Surgical Outcomes After Anatomical endoscopic enucleation of the prostate in Benign Prostatic Hyperplasia
    5. 34.5
      #0510 The risk of Hyponatremia in BPH Patients with Desmopressin use
    6. 34.6
      #0529 Introduction of same-day discharge HoLEP in a district general hospital
    7. 34.7
      #0626 Effectiveness of Fertility Stimulation for Males Post-Transsphenoidal Approach: Identifying High-Risk Patients
    8. 34.8
      #0700 A novel treatment with balloon dilation for panurethral stricture in a patient with recurrent infiltrating urothelial carcinoma of bladder treated with nivolumab
    9. 34.9
      #0719 Slim 22-F versus Standard 26-F Sheath Holmium Laser Enucleation of the Prostate in the Management of Benign Prostatic Hyperplasia: A Prospective, Randomized Controlled Trial
    10. 34.10
      #0723 Proteomic Analysis of Interstitial Fluid in Cryptorchidism Patients and Insights into Sperm Retrieval success
    11. 34.11
      #0865 Autonomic Modulation and Symptomatic Improvement Following Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Prospective Cohort Study
    12. 34.12
      #0868 Impact of Sedentary Occupational Work on Androgen Levels, Prostate-Specific Antigen, and Lower Urinary Tract Symptoms in Male Office Managers: A Cross-Sectional Study
    13. 34.13
      #0899 Microwave Transurethral Thermodilatation Therapy (TUTD) for Symptomatic Benign Prostatic Hyperplasia: 5-Year Follow Up Experience of 35 Asian patients
    14. 34.14
      #0916 GPX4 Expression and Mitochondrial Regulation in Human Ejaculatory Sperm and Seminal Exosome
    15. 34.15
      #0959 Guideline of Guidelines: a comparison of national guidelines on the management of erectile dysfunction
    16. 34.16
      #1058 Microwave Transurethral Thermodilatation Therapy (TUTD) for Symptomatic Benign Prostatic Hyperplasia: 5-Year Follow Up Experience of 35 patients
    17. 34.17
      #1403 Anatomic Endoscopic Enucleation of the Prostate using Mini Bipolar Energy Modality
    18. 34.18
      #1492 Effect of Irrigation Flow Rate, UAS Type and Size, and Extraction Method on the Dissolution and Retrieval Efficiency of Medinik® Hydrogel: An Ex Vivo Study
  35. 35.
    Free Paper <Moderated Poster> (8) Transplantation & AI & Training
    1. 35.1
      #0074 Spontaneous graft rupture in a post RAR day 11 pt with acute graft rejection,managed with rectus sheath patch stiches followed by graft nephrectomy in 24 yrs male pt
    2. 35.2
      #0075 A 33 yrs old male patient 9 months post RAR presented with increasing creatinine lower ureteric stricture n proximal ureteric diverticulum,managed with Pyelo native ureterostomy
    3. 35.3
      #0095 Urolithiasis and common urologic tumors: insights from the NHANES 2007-2018 and bidirectional Mendelian randomization studies
    4. 35.4
      #0183 Management of nocturia due to lower urinary tract symptoms of mixed etiologies: Recommendations from the Community of Nocturia Experts (CONE) panel
    5. 35.5
      #0188 Beyond the Transplant: Exploring Difficult-to-Control Hypertension in Kidney Recipients
    6. 35.6
      #0397 Can AI chatbots deliver high quality and understandable information on penile cancer for patients and their families?
    7. 35.7
      #0632 Simultaneous Pancreas-Kidney Transplantation (SPKT) under the National Pancreas Transplant Programme in Singapore: A Twelve-Year Retrospective Case Series
    8. 35.8
      #0813 A global scoping review of surgeons education and knowledge of how to care for transgender patients
    9. 35.9
      #0829 Hybrid Approach for Post-Renal Transplant Mycotic Pseudoaneurysm: A case study
    10. 35.10
      #0954 Vulnerabilities to stealth prompt injection attacks in medical recommendation systems using large-scale language models: Focusing on urology
    11. 35.11
      #1170 Urology Nurse Practitioner led Clinics in Regional areas
    12. 35.12
      #1194 Trialling Real-World Implementation of AI Voice Dictation in a Urology Outpatient Clinic: A Feasibility Study
    13. 35.13
      #1272 Kidney Transplantation In Patients With Small Bladder Capacity: A Single-Center Experience At Cho Ray Hospital In Vietnam.
    14. 35.14
      #1295 Trends and characteristics of Rapid Response/Medical Emergency Team (MET) calls in a Urology unit in Melbourne, Australia
    15. 35.15
      #1375 Parameters associated with delayed graft function in kidney transplant patients
    16. 35.16
      #1446 Idiopathic bilateral renal hemorrhage: Wunderlich Syndrome
    17. 35.17
      #1482 MAP score as a Risk Factor in Laparoscopic Donor Nephrectomy: A Systematic Review and Meta-Analysis
  36. 36.
    Free Paper <Moderated Poster> (9) Novel Advances
    1. 36.1
      #0384 Robotic Inguinal Hernia Repair: Comparative Study of Senhance and da Vinci Platforms
    2. 36.2
      #0410 Recurrent Sigmoid Volvulus after Robotic-Assisted Laparoscopic Prostatectomy
    3. 36.3
      #0519 NOVEL LOW-COST SYNTHETIC GELATIN MODEL FOR LAPAROSCOPIC URETEROLITHOTOMY TRAINING: A DESCRIPTIVE ANALYSIS OF PARTICIPANT EVALUATION FEEDBACK
    4. 36.4
      #0757 Green synthesis of ZnO nanoparticle as a potential nanocarrier for androgen-resistant prostate cancer
    5. 36.5
      #0837 Targeted Pelvic Lymph Node Dissection with SCOUT for Robotic Prostatectomy
    6. 36.6
      #1045 Adrenalectomy in Regional Australia – A Fifteen-Year Consecutive, Single-Surgeon Series
    7. 36.7
      #1075 Prevalence of BRCA Gene Mutations in Metastatic Prostate Cancer
    8. 36.8
      #1144 Primary versus Sequential MRI for Prostate Cancer Screening: Systematic Review and Meta-analysis
    9. 36.9
      #1199 Optimizing Biopsy Method Selection in Prostate Cancer: Role of DRE and MRI
    10. 36.10
      #1260 Anatomical 3D Models for Retrograde Intrarenal Surgery Training
    11. 36.11
      #1383 Is More Always Better? Evaluating the Addition of TRUS Biopsy to Targeted and Systematic Fusion Prostate Biopsy
    12. 36.12
      #1391 Real-World Outcomes of Darolutamide in Treating Metastatic Castration-Sensitive Prostate Cancer: A Single-Center Experience
    13. 36.13
      #1392 Predictive Accuracy of Stone Size, Volume, and Density, on Surgical Outcomes in Retrograde Intrarenal Surgery for Solitary Renal Stones Less < 2 Cm: a Retrospective Analysis
    14. 36.14
      #1435 A Study on Causes of Death after Permanent Iodine-125 Seed Brachytherapy for Prostate Cancer
    15. 36.15
      #1452 The prognostic significance of undetectable PSA nadir in metastatic hormone-sensitive prostate cancer (mHSPC)
    16. 36.16
      #1466 THE IMPACT OF AUSTRALIAN FEDERAL FUNDING ON REFERRAL PATTERNS OF DIAGNOSTIC MULTI-PARAMETRIC MRI OF THE PROSTATE
    17. 36.17
      #1485 Patient-Reported and Biopsy Outcomes After MRI-US Fusion Transperineal Prostate Biopsy Under Local Anaesthesia: A Single Centre Cohort Study in Malaysia
    18. 36.18
      #1491 Comparison of Four Novel Hormonal Agents in Achieving Ultra-Low PSA and Time to PSA Nadir in mCSPC Patients: A Single-Center Retrospective Study
  37. 37.
    Free Paper <Moderated Poster> (10) Oncology Bladder (B)
    1. 37.1
      #0104 Long-Term Outcomes of Robotic Simultaneous Nephroureterectomy and Radical Cystectomy in End-Stage Renal Disease Patients: A Retrospective Study from a High-Volume Center
    2. 37.2
      #0108 Micro/nanomotors in Biomedicine: Construction and Applications
    3. 37.3
      #0186 An initial pilot study in a porcine model to evaluate the feasibility of robotic retrograde intrarenal surgery using the second version of the robotic flexible ureteroscopy system, ZamenixTMP
    4. 37.4
      #0418 Improving Visual Accuracy and Comfort with Modified Urine Bags
    5. 37.5
      #0551 Dietary index for gut microbiota, a novel protective factor for the prevalence of chronic kidney diseases in the adults: insight from NHANES 2007-2018
    6. 37.6
      #0877 A Profile of Post-Infectious and Post-Inflammatory Urethral Strictures in the Philippines from 2021-2024
    7. 37.7
      #0901 Innovative surgical method to prevent anterior enterocele after robot-assisted radical cystectomy.
    8. 37.8
      #1035 Laparoscopic Pelvic Floor Mesh Fixation and Gracilis Muscle Flap for Recurrent Enterocele After RARC
    9. 37.9
      #1102 Deciphering Cystitis Cystica: Clinical Behavior, Radiological Features and New Management Algorithm
    10. 37.10
      #1141 Optimizing Post-Operative Recovery in Urological Robotic Surgery: Identifying the Ideal ERAS Protocol
    11. 37.11
      #1182 The Comparison of Maintenance and Induction Intravesical Chemotherapy in the Treatment of Non-Muscle Invasive Bladder Cancer
    12. 37.12
      #1190 ALT flap Reconstruction of abdominal defects in Bladder Exstrophy: Technique, complications and rescue procedure
    13. 37.13
      #1258 Functional Impact of Simple Renal Cysts
    14. 37.14
      #1305 Comparative Effectiveness of Neoadjuvant versus Adjuvant Chemotherapy in Invasive Urothelial Carcinoma of the Bladder: A Study Using the TriNetX Research Network
    15. 37.15
      #1354 Bladder Endometriosis Masquerading as a Bladder Mass: A Diagnostic Challenge
    16. 37.16
      #1360 Pathological Complete Response Induced by Enfortumab Vedotin in Locally Advanced Bladder Cancer with Distal Ureter Involvement: A Case Report
    17. 37.17
      #1396 Outcomes of Enfortumab Vedotin in Chronic Kidney Disease Patients with Locally Advanced or Metastatic Urothelial Carcinoma
    18. 37.18
      #1398 Evaluating Perioperative Outcomes in Robotic and Open Repair of Genitourinary Fistulas : A Retrospective Comparative Study
    19. 37.19
      #1484 Systematic Review and Meta-analysis of the Association Between CONUT Score and High-Grade Postoperative Complications in Bladder Cancer Patients Undergoing Radical Cystectomy
地址：台北市 11051 信義區基隆路一段432號6樓之1, 電話：02-2729-0819, 傳真：02-2729-0864
網址: http://eschool.tua.org.tw,  EMail: eschool@tua.org.tw